Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01630993 · ClinicalTrials.gov registry record · Early Phase 1

Milking the Umbilical Cord at Term Cesarean Birth

A Early Phase 1 study of Anemia, sponsored by University of Rhode Island.

Completed
Registry status
Early Phase 1
Development phase
24
Enrollment target
1
Study location

NCT01630993 is a Early Phase 1 study of Anemia that has completed, run by University of Rhode Island. The registered enrollment target is 24 participants, below the 427-participant average among 72 other Anemia trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01630993, a Early Phase 1 study of Anemia, has completed, sponsored by University of Rhode Island.

COMPLETED
Registry status
Early Phase 1
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The purpose of this pilot study is to determine if umbilical cord milking at the time of scheduled cesarean section effects the hemoglobin and hematocrit levels of full-term infants as determined by hemoglobin and hematocrit levels at 36-48 hours of life. This study will help to establish the feasibility of umbilical cord milking as an alternative to delayed clamping at the time of planned cesarean section.

Conditions Studied

Interventions

  • OTHER Umbilical Cord Milking

Study Locations (1)

Rhode Island

  • Women & Infants Hospital - Providence

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2008-05
Est. Completion 2009-12
Phase Early Phase 1

Sponsor

University of Rhode Island

29 total trials

What the Registry Record Tells You About NCT01630993

The ClinicalTrials.gov registry entry for NCT01630993 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 427-participant average among 72 other Anemia trials with a reported enrollment target (94% lower). The listed sponsor is University of Rhode Island, which has 29 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anemia appearing as the primary indexed condition, and to 1 intervention - of which Umbilical Cord Milking is the first listed.

NCT01630993 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.

Frequently Asked Questions

What is clinical trial NCT01630993 about?

NCT01630993 is a clinical study titled "Milking the Umbilical Cord at Term Cesarean Birth". The purpose of this pilot study is to determine if umbilical cord milking at the time of scheduled cesarean section effects the hemoglobin and hematocrit levels of full-term infants as determined by hemoglobin and hematocrit levels at 36-48 hours of life. This study will help to establish the feasib...

What is the current status of trial NCT01630993?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 24 participants. The study started on 2008-05. Estimated completion is 2009-12.

What conditions does trial NCT01630993 study?

This clinical trial studies the following conditions: Anemia.

What interventions are being tested in trial NCT01630993?

The interventions under investigation include: Umbilical Cord Milking (OTHER).

Who is sponsoring clinical trial NCT01630993?

This trial is sponsored by University of Rhode Island, which has 29 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01630993 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.